Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Borealis Ventures is a venture capital firm founded in 2002 and based in the United States. The firm focuses on partnering with entrepreneurs to build companies that aim to transform healthcare through new therapies and digital innovation. Borealis Ventures has a legacy of supporting entrepreneurship at Dartmouth College and invests at the earliest stages in emerging companies.
Borealis Ventures invests in life science platforms, digital health, and animal health. They operate as lifecycle investors, providing resources to portfolio companies and collaborating with syndicate partners. The firm targets pre-seed, seed, seed-plus, and Series A stages, emphasizing innovative therapies and technologies.
Borealis Ventures has backed notable companies in the healthcare sector, including Glaukos, Repligen, Wedgewood, CMPX (NASDAQ), CVET (NASDAQ), Merck, and Altaris.
Email your pitch deck to team@borealis.vc for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.